Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Quinoxaline-5-carbaldehyde → 5-[[4-[3-(Trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]piperazin-1-yl]methyl]quinoxaline
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Quinoxaline-5-carbaldehyde | HCID 582505 | — |
| 반응물 | 6-Piperazino-3-(trifluoromethyl)[1,2,4]triazolo[4,3-b]pyridazine | HCID 1476862 | — |
| 생성물 | 5-[[4-[3-(Trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]piperazin-1-yl]methyl]quinoxaline | HCID 67340878 | — |
반응 단계
Reductive amination of 6-(piperazin-1-yl)-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazine with quinoxaline-5-carbaldehyde was carried out according to General Synthetic Method 7. The crude product was purified by hplc using a Waters XBridge Prep C18 OBD column, 5μ silica, 21 mm diameter, 100 mm length eluted with decreasingly polar mixtures of water (containing 0.05% aqueous ammonia) and acetonitrile as eluents to give 5-[[4-[3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]piperazin-1-yl]methyl]quinoxaline.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US08003649B2 |
| 출처 데이터셋 | uspto-grants-2011_08 |
| ORD ID | ord-1631ca2dd63b403a95d5e64d8fd0275f |
| 출처 메모 | uspto-grants-2011_08 |